CRISPR THERAPEUTICS AG

Ticker: CRSP CUSIP: H17182108 Class: NAMEN AKT

Brevan Howard Capital Management LP's Holding History (CIK: 0001512857)

Note: Option positions (PUT/CALL) are excluded.

Q3 2024
Shares 4,595 Value ($000) $216 Avg Close $50.74 Range $43.42 - $63.68
Q4 2023
Shares 5,812 Value ($000) $364 Avg Close $55.02 Range $37.55 - $76.97
Q1 2021
Shares 14,911 Value ($000) $1,817 Avg Close $151.00 Range $100.00 - $220.20
Q4 2020
Shares 23,200 Value ($000) $3,552 Avg Close $118.20 Range $79.31 - $181.42